Acuamark Diagnostics

At AcuamarkDX, we are shaping a new future in cancer diagnostics and making early cancer detection a standard of primary care. AcuamarkDx is pleased to be featured as a diagnostics company on the rise in the premiere issue of ENMEDIA magazine. Cochrane is the Chair of UNC’s Board of Trustees. Director R&D, Applied Biosystems Inc.; SVP Product Development & CTO, Helicos BioSciences Corp.; SVP R&D, Affymetrix; Independent Consultant. Director, Clinical Affairs and Regulatory Submissions at Abbott Molecular Diagnostics, at Baxter as Director of Clinical Affairs, at Oncor and at Boehringer Mannheim. Flom has led for over 30 products through regulatory filings and registration in the US and numerous international product registrations. Howard is a senior entrepreneurial executive with thirty-years of experience in operations, finance, business development, and investor relations at biotechnology companies. Founded UniTaq Bio to commercialize novel methods for highly multiplexed qPCR for diagnostics.